Higher GABRB3 expression levels were significantly associated with OS in all glioma subtypes, namely astrocytoma, oligoastrocytoma, and oligodendroglioma (Bonferroni-adjusted p < 0.05) (Figure 2). This evidence concerns the gene GABRB3 and central nervous system cancer.